Part III. Dissolution of retained common duct stones.
D000284:Administration, Oral; D001646:Bile / Q000378:metabolism; D001647:Bile Acids and Salts / Q000008:administration & dosage; D002725:Chloroform / Q000008:administration & dosage; D002756:Cholagogues and Choleretics / Q000008:administration & dosage; D002758:Cholangiography; D002769:Cholelithiasis / Q000601:surgery; D002779:Cholestasis / Q000628:therapy; D002784:Cholesterol / Q000378:metabolism; D002793:Cholic Acids / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004987:Ethers / Q000008:administration & dosage; D042882:Gallstones / Q000188:drug therapy*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D006874:Hydrostatic Pressure; D011183:Postoperative Complications / Q000188:drug therapy*; D012965:Sodium Chloride / Q000008:administration & dosage; D012995:Solubility; D007507:Therapeutic Irrigation / Q000379:methods
D001647:Bile Acids and Salts; D002756:Cholagogues and Choleretics; D002793:Cholic Acids; D004987:Ethers; D012965:Sodium Chloride; D002725:Chloroform; D006493:Heparin; D002784:Cholesterol